Modern aminos retatrutide (LY3437943) is a novel investigational peptide that simultaneously activates three metabolic hormone receptors: glucagon (GCG), glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1). This triagonist peptide shows promising research potential in metabolic studies.
Our modern aminos retatrutide is supplied as a white, lyophilized powder with exceptional purity (≥99.88% by HPLC). The product is carefully handled and stored at 2-8°C to maintain stability, with a shelf life of 24 months when properly stored.
As a research-grade compound, modern aminos retatrutide is offered in various dosage options to accommodate different study requirements. The product is strictly for laboratory research use only and not intended for human consumption.
Modern aminos retatrutide represents an exciting development in peptide research, with potential applications in metabolic studies. Its unique triple-receptor activation mechanism makes it particularly interesting for scientific investigation.